Concurrent chemoradiotherapy using cisplatin plus s-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: A single-center feasibility study

[1] Albain K.S.(2009)Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 379-386

[2] Swann R.S.(2007)Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 442-450

[3] Rusch V.W.(1992)Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 524-530

[4] Turrisi A.T.(2000)A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced nonsmall-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group Br J Cancer 82 104-111

[5] Shepherd F.A.(2004)Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial Clin Cancer Res 10 4369-4373

[6] Smith C.(2003)Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer Ann Thorac Surg 76 1810-1814

[7] van Meerbeeck J.P.(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumour selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-557

[8] Kramer G.W.P.M.(2009)Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer Br J Cancer 101 225-231

[9] Van Schil P.E.Y.(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216

[10] Legrand C.(1958)Nonparametric estimation from incomplete observation J Am Stat Assoc 53 457-481

[1] Albain K.S.(2009)Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 379-386

[2] Swann R.S.(2007)Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 442-450

[3] Rusch V.W.(1992)Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 524-530

[4] Turrisi A.T.(2000)A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced nonsmall-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group Br J Cancer 82 104-111

[5] Shepherd F.A.(2004)Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial Clin Cancer Res 10 4369-4373

[6] Smith C.(2003)Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer Ann Thorac Surg 76 1810-1814

[7] van Meerbeeck J.P.(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumour selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-557

[8] Kramer G.W.P.M.(2009)Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer Br J Cancer 101 225-231

[9] Van Schil P.E.Y.(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216

[10] Legrand C.(1958)Nonparametric estimation from incomplete observation J Am Stat Assoc 53 457-481